Medical therapy of inflammatory bowel disease

S. B. Hanauer*, F. Baert

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Despite advances in pharmacologic approaches, the treatment of ulcerative colitis and Crohn's disease remains a challenge. Prior standards of therapy, sulfasalazine and corticosteroids, are gradually being replaced by mesalamine and alternative immune modulating agents. This article discusses the important pharmacologic properties, mechanisms of action, indications, and complications necessary to apply the expanding armamentarium in clinical practice.

Original languageEnglish (US)
Pages (from-to)1413-1426
Number of pages14
JournalMedical Clinics of North America
Issue number6
StatePublished - 1994

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Medical therapy of inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this